对同情性质的阻塞改善了在败血症休克时的血管功能障碍
Ana Maria Favero1, Thiele Osvaldt Rosales2, Karin Scheschowitsch1
1Department of Pharmacology, Center of Biological Sciences, Universidade Federal de Santa Catarina, Florianopolis, SC, Brazil.
Naunyn-Schmiedeberg's archives of pharmacology
|March 8, 2024
概括
减少过度的交感神经系统激活与质阻塞剂改善了实验性败血症的血管功能. 这种方法可以通过保持上腺素受体密度和减少炎症,为败血症提供新的治疗方法.
科学领域:
- 药理学 药理学是指药理学的学科.
- 生理学 生理学 生理学
- 免疫学 免疫学 免疫学
背景情况:
- 败血症激活了交感神经系统 (SNS),可能导致自主功能障碍.
- 过度的SNS激活有助于在败血症期间血管功能障碍.
研究的目的:
- 为了研究质传播在败血症引起的血管功能障碍中的作用.
- 在实验性败血症中评估质阻塞剂的治疗潜力.
主要方法:
- 在大鼠中,通过结和穿孔 (CLP) 诱导了败血症.
- 鼠被用质阻断剂 (六甲或) 或车载药物治疗.
- 评估了血管反应,上腺素受体密度,细胞因子水平和氧化合成酶2 (NOS-2) 表达.
主要成果:
- 败血症导致低血压,对上腺激动剂的低反应,以及增加NOS-2表达和细胞因子.
- 丁,但不是六甲,恢复了上腺素受体密度和反应能力.
- 这两种抑制剂都改善了血管缩反应,并减少了NOS-2和炎症标志物.
结论:
- 阻断交感性质传播改善了实验性败血症中的血管功能障碍.
- 维护α1上腺素受体密度和减少NOS-2表达有助于有益的效果.
- 腺阻断剂代表了人类败血症的潜在辅助疗法.
相关概念视频
Drugs Acting on Autonomic Ganglia: Blockers
1.0K
Ganglionic blockers inhibit autonomic activity by blocking nicotinic receptors in the autonomic ganglia, suppressing impulse transmission. These blockers lack selectivity between sympathetic and parasympathetic ganglia and are ineffective as neuromuscular junction antagonists. They can be categorized into two groups:
1.0K
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
429
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
429
Heart Failure Drugs: β-Blockers
338
β-adrenergic antagonists, commonly known as β-blockers, block the effects of sympathetic neurotransmitters such as noradrenaline (NA) and adrenaline (ADR). They have several beneficial effects in heart failure treatment. They reduce heart rate, the force of contraction, and cardiac muscle relaxation. They also slow the atrial-ventricular conduction rate and raise the threshold for arrhythmias. The concentration of β-blockers determines their effects on bronchodilation,...
338
Blood Pressure Imbalances and Circulatory Shock
774
Disorders affecting blood volume, vascular tone, or vascular function can disrupt vascular homeostasis, including conditions like hypertension, hemorrhage, and shock.
Blood Pressure: Hypertension and Hypotension
Normal blood pressure is 120/80 mm Hg. Elevated blood pressure is 120-129/under 80 mm Hg. Hypertension, warranting treatment at 130/80 mm Hg, is often asymptomatic and can lead to severe cardiovascular events, aneurysms, peripheral arterial disease, chronic renal disease, or cardiac...
Blood Pressure: Hypertension and Hypotension
Normal blood pressure is 120/80 mm Hg. Elevated blood pressure is 120-129/under 80 mm Hg. Hypertension, warranting treatment at 130/80 mm Hg, is often asymptomatic and can lead to severe cardiovascular events, aneurysms, peripheral arterial disease, chronic renal disease, or cardiac...
774
Disorders of the Autonomic Nervous System
637
The autonomic nervous system (ANS) is an intricate network of nerves that controls functions such as the regulation of heart rate, digestion, and blood pressure regulation. When this system malfunctions, it can lead to various disorders that affect multiple bodily functions. One common feature of many autonomic disorders is the involvement of smooth blood vessels, which play a crucial role in regulating blood flow throughout the body.
Raynaud's disease, also known as Raynaud's...
Raynaud's disease, also known as Raynaud's...
637
Antihypertensive Drugs: Vasodilators
519
Vasodilators, primarily affecting the smooth muscles within arterial and venous walls, are commonly used for hypertension treatment. Medications such as minoxidil and hydralazine primarily target arteries and arterioles, while sodium nitroprusside acts on arterioles and venules. Minoxidil, functioning as a prodrug, is metabolized by hepatic sulfotransferase into its active form, minoxidil sulfate, after oral administration. This metabolite binds to the sulfonylurea receptor (SUR) component of...
519


